SANUWAVE Health, Inc. Form 8-K Summary
Business Context and Reporting Period
Filed September 25, 2026, regarding a Nasdaq listing-compliance notice received September 23, 2026. The filing concerns SANUWAVE Health, Inc.’s common stock, traded under the symbol SNWV on The Nasdaq Global Market.
Financial Metrics and Liquidity
This Form 8-K does not provide revenue, earnings, cash flow, margins, debt, liquidity, or other operating-financial metrics. The filing states that the company’s Market Value of Listed Securities (MVLS) was below $50 million for the last 30 consecutive business days.
Material Changes and Listing Status
- Nasdaq notified the company that it was not meeting the continued-listing requirement under Nasdaq Listing Rule 5450(b)(2)(A), which requires minimum MVLS of $50 million for listing on The Nasdaq Global Market.
- The notice has no immediate effect on the listing. The company’s common stock will continue trading on The Nasdaq Global Market, subject to other listing requirements.
- The company has 180 calendar days from the notice date, through March 22, 2027, to regain compliance.
- Compliance will be restored if MVLS closes at or above $50 million for at least 10 consecutive business days during the compliance period, subject to Nasdaq’s written confirmation.
Outlook, Risks, and Contingencies
If compliance is not restored by March 22, 2027, Nasdaq is expected to notify the company that its securities are subject to delisting. The company may alternatively apply to transfer its securities to The Nasdaq Capital Market if it satisfies that market’s continued-listing requirements.
Management stated that it intends to monitor MVLS and consider available options, but there is no assurance that the company will maintain its Nasdaq Global Market listing or qualify for a transfer to the Nasdaq Capital Market. The filing identifies future financial results and stock-price performance as factors that could affect compliance and includes customary forward-looking-statement risk disclosures.
Key Facts for Investors to Verify
- Whether MVLS reaches at least $50 million for 10 consecutive business days before March 22, 2027.
- Any subsequent Nasdaq correspondence regarding compliance, delisting, or a market transfer.
- Whether the company continues to satisfy all other Nasdaq listing requirements.
- The company’s financial condition, operating results, cash position, and capital needs, which are not disclosed in this filing.